Product Use Citations
-
Peng Y, et al. The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121
Biochem Biophys Res Commun. 2015, 465(1):137-44.
PP121 purchased from Selleck.
-
Tomida C, et al. Chronic exposure of VEGF inhibitors promotes the malignant phenotype of colorectal cancer cells.
J Med Invest. 2015, 62(1-2):75-9.
Foretinib (GSK1363089) purchased from Selleck.
-
Diculescu VC, et al. In situ electrochemical evaluation of dsDNA interaction with the anticancer drug danusertib nitrenium radical product using the DNA-electrochemical biosensor.
Bioelectrochemistry. 2016, 107:50-7.
Danusertib (PHA-739358) purchased from Selleck.
-
Song C, et al. Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion.
Biochim Biophys Acta. 2017, 1861(4):947-957.
-
Parra K, et al. Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth.
Br J Cancer. 2017, 116(3):324-334.
Gemcitabine HCl purchased from Selleck.
-
Packer L, et al. PI3K inhibitors synergize with FGFR inhibitors to enhance antitumor responses in FGFR2-mutant endometrial cancers.
Mol Cancer Ther. 2017, 10.1158/1535-7163.
Pictilisib (GDC-0941) , Alpelisib (BYL719) and Buparlisib (BKM120, NVP-BKM120) purchased from Selleck.
-
Cardnell RJ, et al. Activation of the PI3K/mTOR pathway following PARP Inhibition in small cell lung cancer.
PLoS One. 2016, 10.1371/journal.
Buparlisib (BKM120, NVP-BKM120) purchased from Selleck.
-
Herrero-Sánchez MC, et al. Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development.
J Hematol Oncol. 2016, 9(1):113.
Buparlisib (BKM120, NVP-BKM120) purchased from Selleck.
-
Ma P, et al. Adaptive and acquired resistance to EGFR inhibitors converge on the MAPK pathway
Theranostics. 2016, 6(8):1232-43.
Foretinib (GSK1363089) purchased from Selleck.
-
Song JH, et al. Insulin receptor substrate 1 is a substrate of the Pim protein kinases.
Oncotarget. 2016, 7(15):20152-65.
Torkinib (PP242) purchased from Selleck.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
AllPage:
Page:
